Literature DB >> 2175292

Association of autoimmune hepatitis with HLA-Bw54 and DR4 in Japanese patients.

T Seki1, K Kiyosawa, H Inoko, M Ota.   

Abstract

Human leukocyte antigen-D region-related alleles (human leukocyte antigen DR and DQ) and human leukocyte antigen class I alleles were typed serologically in 31 Japanese patients with autoimmune hepatitis. These patients had increased serum levels of AST and IgG, high titers of autoantibodies, no history of blood transfusion and were negative for HBsAg and antibodies to HBc. Three hundred eighty-six healthy subjects and 30 patients with cryptogenic chronic hepatitis served as control groups. The frequency of DR4 was significantly higher in autoimmune hepatitis patients (90.3%) than in healthy subjects (38.6%) and in cryptogenic chronic hepatitis patients (30%). The frequency of Bw54 was significantly higher in autoimmune hepatitis patients (45.2%) than in healthy subjects (10.9%). The risk to DR4-positive subjects for autoimmune hepatitis was 14.8 relative to healthy subjects. Two of 31 patients (6.5%) with autoimmune hepatitis were positive for antibody to hepatitis C virus; both clearly satisfied criteria for autoimmune hepatitis and both had Bw54 and DR4. This study revealed a highly significant association of autoimmune hepatitis with human leukocyte antigen Bw54 and DR4 in Japanese patients. Among the DR4-positive patients with autoimmune hepatitis, no significant differences were seen between those positive or negative for Bw54 with regard to clinical or laboratory data, relapse of disease or efficacy of prednisolone. Thus human leukocyte antigen class II alleles contribute to susceptibility and resistance to autoimmune hepatitis in Japanese patients, with distinct racial differences from those in white patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2175292     DOI: 10.1002/hep.1840120609

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  22 in total

Review 1.  Genetic bases of autoimmune hepatitis.

Authors:  Albert J Czaja; Derek G Doherty; Peter T Donaldson
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199

2.  A possible association between basic amino acids of position 13 of DRB1 chains and autoimmune hepatitis.

Authors:  M Ota; T Seki; K Kiyosawa; S Furuta; K Hino; T Kondo; H Fukushima; K Tsuji; H Inoko
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

3.  Antibodies to Ro/La, Cenp-B, and snRNPs antigens in autoimmune hepatitis of North America versus Asia: patterns of immunofluorescence, ELISA reactivities, and HLA association.

Authors:  S Parveen; S A Morshed; K Arima; M Nishioka; A J Czaja; W C Chow; H S Ng
Journal:  Dig Dis Sci       Date:  1998-06       Impact factor: 3.199

4.  An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitis.

Authors:  Akiko Hisamochi; Masayoshi Kage; Tatsuya Ide; Teruko Arinaga-Hino; Keisuke Amano; Reiichiro Kuwahara; Kei Ogata; Ichiro Miyajima; Ryukichi Kumashiro; Michio Sata; Takuji Torimura
Journal:  J Gastroenterol       Date:  2015-10-30       Impact factor: 7.527

Review 5.  Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2015-05-22       Impact factor: 3.199

6.  Genetic distinctions between autoimmune hepatitis in Italy and North America.

Authors:  Paolo Muratori; Albert-J Czaja; Luigi Muratori; Georgios Pappas; Silvana Maccariello; Fabio Cassani; Alessandro Granito; Rodolfo Ferrari; Vilma Mantovani; Marco Lenzi; Francesco-B Bianchi
Journal:  World J Gastroenterol       Date:  2005-03-28       Impact factor: 5.742

7.  Type 1 autoimmune hepatitis in Taiwan: diagnosis using the revised criteria of the International Autoimmune Hepatitis Group.

Authors:  Lok-Beng Koay; Ching-Yih Lin; Sun-Lung Tsai; Chuan Lee; Ching-Nan Lin; Ming-Juen Sheu; Hsing-Tao Kuo; Chi-Shu Sun
Journal:  Dig Dis Sci       Date:  2006-10-20       Impact factor: 3.199

Review 8.  Autoimmune hepatitis. Evolving concepts and treatment strategies.

Authors:  A J Czaja
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

Review 9.  Acute and acute severe (fulminant) autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2012-10-23       Impact factor: 3.199

10.  Increased bcl-2 expression in lymphocytes and its association with hepatocellular damage in patients with autoimmune hepatitis.

Authors:  M Yachida; K Kurokohchi; K Arima; M Nishioka
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.